查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1631233

持续血糖监测系统的全球市场 - 全球产业分析，规模，占有率，成长，趋势，预测(2032年)

Continuous Glucose Monitoring Systems Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032
出版日期: | 出版商: Fairfield Market Research | 英文 217 Pages | 商品交期: 2-5个工作天内

价格
简介目录

受技术进步和糖尿病盛行率上升的推动，全球持续血糖监测 (CGM) 系统市场规模预计将在未来几年显着增长。预计将以 9.3% 的强劲复合年增长率成长，到 2025 年达到 131.4 亿美元，到 2032 年达到 244.9 亿美元。 CGM 系统正在彻底改变糖尿病管理，提供对血糖变化的即时洞察并实现主动护理。

持续血糖监测系统使用先进的感测器来提供准确、即时的血糖数据，而无需频繁进行手指刺穿测试。这种创新方法提高了患者和医疗保健提供者管理糖尿病的能力。人们越来越意识到这些系统的益处、血糖控制能力的提高以及糖尿病管理的便利性，从而推动了这些系统的采用。 CGM 系统与数位健康生态系统的整合进一步增加了这种需求。

由于数位健康整合、个人化医疗和不断扩大的区域市场带来的巨大机遇，持续血糖监测系统市场有望实现转型成长。技术进步和支持性医疗政策将继续影响市场轨迹，推动创新并确保广泛获得有效的糖尿病管理解决方案。

感测器技术的不断创新使得 CGM 系统更加准确、可靠且易于使用。透过人工智慧和机器学习提高的数据分析能力将为更好地管理糖尿病提供可行的见解。久坐的生活方式和不健康的饮食习惯的增加导致全球糖尿病盛行率上升，迫切需要有效的血糖监测解决方案。在北美等地区，全面的报销措施和支援性监管框架正在推动 CGM 设备的采用。

本报告提供全球持续血糖监测系统市场相关调查，提供市场概要，以及各零件，各终端用户，及各地区趋势，及市场参与市场企业的竞争趋势等资讯。

目录

第1章 摘要整理

第2章 市场概要

  • 市场定义和市场区隔
  • 市场动态
  • 价值链分析
  • 波特的五力分析
  • COVID-19影响分析
  • 乌克兰·俄罗斯纠纷的影响
  • 经济概要
  • 大环境分析

第3章 产量与贸易统计，2019年～2023年

第4章 价格分析，2019年～2023年

第5章 全球持续血糖监测系统市场预测，2019年～2032年

  • 全球持续血糖监测系统市场预测，各零件，金额(10亿美元)，数量(100万台)，2019年～2032年
  • 全球持续血糖监测系统市场预测，各终端用户，金额(10亿美元)，数量(100万台)，2019年～2032年
  • 全球持续血糖监测系统市场预测，各地区，金额(10亿美元)，数量(100万台)，2019年～2032年

第6章 北美的持续血糖监测系统市场预测，2019年～2032年

第7章 欧洲的持续血糖监测系统市场预测，2019年～2032年

第8章 亚太地区的持续血糖监测系统市场预测，2019年～2032年

第9章 南美的持续血糖监测系统市场预测，2019年～2032年

第10章 中东·非洲的持续血糖监测系统市场预测，2019年～2032年

第11章 竞争情形

  • 各製造厂商和各终端用户的热图
  • 企业市场占有率分析，2022年
  • 竞争仪表板
  • 企业简介
    • Herbalife Nutrition
    • GNC Holdings
    • NOW Health
    • Nutramax Laboratories
    • Nature's Bounty
    • Banyan Botanicals
    • Source Naturals
    • Nutramarks Inc
    • Nature's Way Products
    • Abbott
    • Natural Immunogenics

第12章 附录

简介目录

The global continuous glucose monitoring (CGM) systems market is set to witness significant growth in the coming years, driven by technological advancements and increasing diabetes prevalence. Forecasted to expand at a robust CAGR of 9.3%, the market is projected to achieve a valuation of $13.14 billion by 2025 and $24.49 billion by 2032. CGM systems have revolutionized diabetes management, offering real-time insights into glucose fluctuations and enabling proactive care.

Market Insights

Continuous glucose monitoring systems utilize advanced sensors to provide accurate, real-time glucose data without the need for frequent finger stick tests. This innovative approach has enhanced the ability of patients and healthcare providers to manage diabetes effectively. The adoption of these systems is being propelled by growing awareness of their benefits, improved glycemic control capabilities, and convenience in diabetes management. The integration of CGM systems with digital health ecosystems has further amplified their demand.

The continuous glucose monitoring systems market is poised for transformative growth, with significant opportunities emerging in digital health integration, personalized medicine, and expanding regional markets. Technological advancements and supportive healthcare policies will continue to shape the trajectory of the market, driving innovation and ensuring broader access to effective diabetes management solutions.

Key Market Drivers

  • Technological Advancements: Continuous innovation in sensor technology has enhanced the accuracy, reliability, and user-friendliness of CGM systems. Improved data analytics capabilities, powered by artificial intelligence and machine learning, provide actionable insights for better diabetes management.
  • Increasing Diabetes Prevalence: A rise in sedentary lifestyles and unhealthy dietary habits has escalated diabetes cases globally, creating a pressing need for effective glucose monitoring solutions.
  • Favorable Government Policies: Comprehensive reimbursement initiatives and supportive regulatory frameworks in regions like North America have encouraged the adoption of CGM devices.

Business Opportunities

  • Integration with Digital Health Platforms: CGM devices are increasingly being integrated with health apps, electronic health records (EHRs), and telehealth services, enabling comprehensive diabetes care and personalized interventions.
  • Emerging Markets in Asia Pacific: The rapidly growing diabetic population and healthcare infrastructure advancements in Asia Pacific present lucrative opportunities for CGM device manufacturers.
  • Expansion of Home Care Diagnostics: With a growing preference for decentralized healthcare, home care diagnostics is becoming a key segment, offering convenience and real-time glucose monitoring.

Regional Analysis

  • North America: The region dominates the global CGM market, supported by robust healthcare infrastructure, high diabetes prevalence, and significant investments in research and development. Favorable reimbursement policies further boost market growth.
  • Asia Pacific: Expected to register the fastest CAGR through 2032, the region's market growth is driven by an expanding diabetic population and increased adoption of advanced healthcare technologies in countries like China and India.
  • Europe: The market benefits from supportive government policies and rising awareness of advanced diabetes management solutions among healthcare providers and patients.

Key Players in the Market

Leading companies are implementing strategies to strengthen their market position:

  • Dexcom: Known for its advancements in sensor technology, offering devices with enhanced accuracy and longer operational durations.
  • Medtronic: Provides integrated diabetes management solutions combining CGM and insulin delivery systems.
  • Abbott Laboratories: Sets a benchmark for ease of use and affordability with its FreeStyle Libre system. Other notable players include Nature's Way Products, GNC Holdings, Banyan Botanicals, Nutramax Laboratories, and more.

Some key companies are:

  • Herbalife Nutrition
  • GNC Holdings
  • NOW Health
  • Nutramax Laboratories
  • Nature's Bounty
  • Banyan Botanicals
  • Source Naturals
  • Nutramarks Inc
  • Nature's Way Products
  • Abbott
  • Natural Immunogenics

Market Segmentation

  • By Component: Transmitters and Monitors Sensors Insulin Pumps
  • By End User: Home Care Diagnostics Hospitals ICU/Critical Care
  • By Region: North America Europe Asia Pacific Latin America Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Continuous Glucose Monitoring Systems Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Volume and Value, 2024
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. Covid-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. Pestle Analysis

3. Production Output and Trade Statistics, 2019 - 2023

  • 3.1. Global Continuous Glucose Monitoring Systems Market Production Output, by Region, Value (US$ Bn) and Volume (Million Units), 2019 - 2023
    • 3.1.1. North America
    • 3.1.2. Europe
    • 3.1.3. Asia Pacific
    • 3.1.4. Latin America
    • 3.1.5. Middle East and Africa

4. Price Analysis, 2019 - 2023

  • 4.1. Global Average Price Analysis, by Component, US$ Per Unit, 2019 - 2023
  • 4.2. Prominent Factor Affecting Continuous Glucose Monitoring Systems Prices
  • 4.3. Global Average Price Analysis, by Region, US$ Per Unit, 2019 - 2023

5. Global Continuous Glucose Monitoring Systems Market Outlook, 2019 - 2032

  • 5.1. Global Continuous Glucose Monitoring Systems Market Outlook, by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 5.1.1. Key Highlights
      • 5.1.1.1. Transmitters and Monitors
      • 5.1.1.2. Sensors
      • 5.1.1.3. Insulin Pump
  • 5.2. Global Continuous Glucose Monitoring Systems Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 5.2.1. Key Highlights
      • 5.2.1.1. Home Care Diagnostics
      • 5.2.1.2. Hospitals
      • 5.2.1.3. ICU/Critical Care
  • 5.3. Global Continuous Glucose Monitoring Systems Market Outlook, by Region, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 5.3.1. Key Highlights
      • 5.3.1.1. North America
      • 5.3.1.2. Europe
      • 5.3.1.3. Asia Pacific
      • 5.3.1.4. Latin America
      • 5.3.1.5. Middle East & Africa

6. North America Continuous Glucose Monitoring Systems Market Outlook, 2019 - 2032

  • 6.1. North America Continuous Glucose Monitoring Systems Market Outlook, by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 6.1.1. Key Highlights
      • 6.1.1.1. Transmitters and Monitors
      • 6.1.1.2. Sensors
      • 6.1.1.3. Insulin Pump
  • 6.2. North America Continuous Glucose Monitoring Systems Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 6.2.1. Key Highlights
      • 6.2.1.1. Home Care Diagnostics
      • 6.2.1.2. Hospitals
      • 6.2.1.3. ICU/Critical Care
    • 6.2.2. BPS Analysis/Market Attractiveness Analysis
  • 6.3. North America Continuous Glucose Monitoring Systems Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 6.3.1. Key Highlights
      • 6.3.1.1. U.S. Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 6.3.1.2. U.S. Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 6.3.1.3. Canada Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 6.3.1.4. Canada Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 6.3.2. Bps Analysis/Market Attractiveness Analysis

7. Europe Continuous Glucose Monitoring Systems Market Outlook, 2019 - 2032

  • 7.1. Europe Continuous Glucose Monitoring Systems Market Outlook, by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.1.1. Key Highlights
      • 7.1.1.1. Transmitters and Monitors
      • 7.1.1.2. Sensors
      • 7.1.1.3. Insulin Pump
  • 7.2. Europe Continuous Glucose Monitoring Systems Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.2.1. Key Highlights
      • 7.2.1.1. Home Care Diagnostics
      • 7.2.1.2. Hospitals
      • 7.2.1.3. ICU/Critical Care
    • 7.2.2. BPS Analysis/Market Attractiveness Analysis
  • 7.3. Europe Continuous Glucose Monitoring Systems Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.3.1. Key Highlights
      • 7.3.1.1. Germany Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 7.3.1.2. Germany Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 7.3.1.3. U.K. Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 7.3.1.4. U.K. Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 7.3.1.5. France Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 7.3.1.6. France Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 7.3.1.7. Italy Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 7.3.1.8. Italy Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 7.3.1.9. Turkey Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 7.3.1.10. Turkey Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 7.3.1.11. Russia Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 7.3.1.12. Russia Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 7.3.1.13. Rest Of Europe Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 7.3.1.14. Rest Of Europe Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.3.2. Bps Analysis/Market Attractiveness Analysis

8. Asia Pacific Continuous Glucose Monitoring Systems Market Outlook, 2019 - 2032

  • 8.1. Asia Pacific Continuous Glucose Monitoring Systems Market Outlook, by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 8.1.1. Key Highlights
      • 8.1.1.1. Transmitters and Monitors
      • 8.1.1.2. Sensors
      • 8.1.1.3. Insulin Pump
  • 8.2. Asia Pacific Continuous Glucose Monitoring Systems Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 8.2.1. Key Highlights
      • 8.2.1.1. Home Care Diagnostics
      • 8.2.1.2. Hospitals
      • 8.2.1.3. ICU/Critical Care
    • 8.2.2. BPS Analysis/Market Attractiveness Analysis
  • 8.3. Asia Pacific Continuous Glucose Monitoring Systems Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 8.3.1. Key Highlights
      • 8.3.1.1. China Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 8.3.1.2. China Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 8.3.1.3. Japan Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 8.3.1.4. Japan Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 8.3.1.5. South Korea Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 8.3.1.6. South Korea Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 8.3.1.7. India Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 8.3.1.8. India Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 8.3.1.9. Southeast Asia Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 8.3.1.10. Southeast Asia Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 8.3.1.11. Rest Of Asia Pacific Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 8.3.1.12. Rest Of Asia Pacific Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Latin America Continuous Glucose Monitoring Systems Market Outlook, 2019 - 2032

  • 9.1. Latin America Continuous Glucose Monitoring Systems Market Outlook, by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 9.1.1. Key Highlights
      • 9.1.1.1. Transmitters and Monitors
      • 9.1.1.2. Sensors
      • 9.1.1.3. Insulin Pump
  • 9.2. Latin America Continuous Glucose Monitoring Systems Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 9.2.1. Key Highlights
      • 9.2.1.1. Home Care Diagnostics
      • 9.2.1.2. Hospitals
      • 9.2.1.3. ICU/Critical Care
    • 9.2.2. BPS Analysis/Market Attractiveness Analysis
  • 9.3. Latin America Continuous Glucose Monitoring Systems Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 9.3.1. Key Highlights
      • 9.3.1.1. Brazil Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 9.3.1.2. Brazil Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 9.3.1.3. Mexico Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 9.3.1.4. Mexico Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 9.3.1.5. Argentina Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 9.3.1.6. Argentina Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 9.3.1.7. Rest Of Latin America Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 9.3.1.8. Rest Of Latin America Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 9.3.2. Bps Analysis/Market Attractiveness Analysis

10. Middle East & Africa Continuous Glucose Monitoring Systems Market Outlook, 2019 - 2032

  • 10.1. Middle East & Africa Continuous Glucose Monitoring Systems Market Outlook, by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 10.1.1. Key Highlights
      • 10.1.1.1. Transmitters and Monitors
      • 10.1.1.2. Sensors
      • 10.1.1.3. Insulin Pump
  • 10.2. Middle East & Africa Continuous Glucose Monitoring Systems Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 10.2.1. Key Highlights
      • 10.2.1.1. Home Care Diagnostics
      • 10.2.1.2. Hospitals
      • 10.2.1.3. ICU/Critical Care
    • 10.2.2. BPS Analysis/Market Attractiveness Analysis
  • 10.3. Middle East & Africa Continuous Glucose Monitoring Systems Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 10.3.1. Key Highlights
      • 10.3.1.1. GCC Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 10.3.1.2. GCC Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 10.3.1.3. South Africa Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 10.3.1.4. South Africa Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 10.3.1.5. Egypt Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 10.3.1.6. Egypt Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 10.3.1.7. Nigeria Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 10.3.1.8. Nigeria Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 10.3.1.9. Rest Of Middle East & Africa Continuous Glucose Monitoring Systems Market by Component, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 10.3.1.10. Rest Of Middle East & Africa Continuous Glucose Monitoring Systems Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 10.3.2. BPS Analysis/Market Attractiveness Analysis

11. Competitive Landscape

  • 11.1. Manufacturer Vs by End User Heatmap
  • 11.2. Company Market Share Analysis, 2022
  • 11.3. Competitive Dashboard
  • 11.4. Company Profiles
    • 11.4.1. Herbalife Nutrition
      • 11.4.1.1. Company Overview
      • 11.4.1.2. Component Portfolio
      • 11.4.1.3. Financial Overview
      • 11.4.1.4. Business Strategies and Development
    • 11.4.2. GNC Holdings
      • 11.4.2.1. Company Overview
      • 11.4.2.2. Component Portfolio
      • 11.4.2.3. Financial Overview
      • 11.4.2.4. Business Strategies and Development
    • 11.4.3. NOW Health
      • 11.4.3.1. Company Overview
      • 11.4.3.2. Component Portfolio
      • 11.4.3.3. Financial Overview
      • 11.4.3.4. Business Strategies and Development
    • 11.4.4. Nutramax Laboratories
      • 11.4.4.1. Company Overview
      • 11.4.4.2. Component Portfolio
      • 11.4.4.3. Financial Overview
      • 11.4.4.4. Business Strategies and Development
    • 11.4.5. Nature's Bounty
      • 11.4.5.1. Company Overview
      • 11.4.5.2. Component Portfolio
      • 11.4.5.3. Financial Overview
      • 11.4.5.4. Business Strategies and Development
    • 11.4.6. Banyan Botanicals
      • 11.4.6.1. Company Overview
      • 11.4.6.2. Component Portfolio
      • 11.4.6.3. Financial Overview
      • 11.4.6.4. Business Strategies and Development
    • 11.4.7. Source Naturals
      • 11.4.7.1. Company Overview
      • 11.4.7.2. Component Portfolio
      • 11.4.7.3. Financial Overview
      • 11.4.7.4. Business Strategies and Development
    • 11.4.8. Nutramarks Inc
      • 11.4.8.1. Company Overview
      • 11.4.8.2. Component Portfolio
      • 11.4.8.3. Financial Overview
      • 11.4.8.4. Business Strategies and Development
    • 11.4.9. Nature's Way Products
      • 11.4.9.1. Company Overview
      • 11.4.9.2. Component Portfolio
      • 11.4.9.3. Financial Overview
      • 11.4.9.4. Business Strategies and Development
    • 11.4.10. Abbott
      • 11.4.10.1. Company Overview
      • 11.4.10.2. Component Portfolio
      • 11.4.10.3. Financial Overview
      • 11.4.10.4. Business Strategies and Development
    • 11.4.11. Natural Immunogenics
      • 11.4.11.1. Company Overview
      • 11.4.11.2. Component Portfolio
      • 11.4.11.3. Financial Overview
      • 11.4.11.4. Business Strategies and Development

12. Appendix

  • 12.1. Research Methodology
  • 12.2. Report Assumptions
  • 12.3. Acronyms And Abbreviations